Barba T
Imperial College London, London, UK. tommaso.barba20@imperial.ac.uk.
ArticleDMT
A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial.
ArticlePsilocybin
Associations of Couples' Psychedelic Use with Shared Reality and Relational Well-Being.
PreprintDMT
Neural effects and phenomenology of nondual meditation and 5-MeO-DMT in an expert meditation practitioner
PreprintDMT
Neural effects and phenomenology of nondual meditation and 5-MeO-DMT in an expert meditation practitioner
ArticleDMT
Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness.
ArticlePsychedelics
Neuroimaging and the Investigation of Drug-Drug Interactions Involving Psychedelics.
ArticlePsilocybin
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.
ArticlePsilocybin
Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".
ArticlePsilocybin
Psychedelics and the 'inner healer': Myth or mechanism?
ArticlePsilocybin
Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.
ArticlePsilocybin
Psychedelics and sexual functioning: a mixed-methods study.
ArticlePsychedelics
Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study.
ArticleDMT
Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial.
ArticlePsychedelics
Psychedelic therapy in the treatment of addiction: the past, present and future.
ArticlePsilocybin